Literature DB >> 26945816

Brief Report: Peripheral Osteolysis in Adults Linked to ASAH1 (Acid Ceramidase) Mutations: A New Presentation of Farber's Disease.

Luisa Bonafé1, Ariana Kariminejad2, Jia Li3, Beryl Royer-Bertrand3, Virginie Garcia4, Shokouholsadat Mahdavi5, Bita Bozorgmehr2, Ralph L Lachman6, Lauréane Mittaz-Crettol1, Belinda Campos-Xavier1, Sheela Nampoothiri7, Sheila Unger1, Carlo Rivolta3, Thierry Levade4, Andrea Superti-Furga1.   

Abstract

OBJECTIVE: To establish a diagnosis and provide counseling and treatment for 3 adult patients from one family presenting with peripheral osteolysis.
METHODS: Following clinical and radiographic assessment, exome sequencing, targeted gene resequencing, and determination of enzyme activity in cultured fibroblasts were performed.
RESULTS: The proband (age 40 years) had a history of episodic fever and pain in childhood that subsided around puberty. He and 2 of his older sisters (ages 58 and 60 years, respectively) showed adult-onset progressive shortening of fingers and toes with redundancy of the overlying skin. Radiographs showed severe osteolysis of the distal radius and ulna, carpal bones, metacarpal bones, and phalanges. Sequencing of the known genes for recessively inherited osteolysis, MMP2 and MMP14, failed to show pathogenic mutations. Exome sequencing revealed compound heterozygosity for mutations c.505T>C (p.Trp169Arg) and c.760A>G (p.Arg254Gly) in ASAH1, the gene coding for acid ceramidase. Sanger sequencing confirmed correct segregation in the family, and enzyme activity in fibroblast cultures from the patients was reduced to ∼8% of that in controls, confirming a diagnosis of Farber's disease.
CONCLUSION: Our findings indicate that hypomorphic mutations in ASAH1 may result in an osteoarticular phenotype with a juvenile phase resembling rheumatoid arthritis that evolves to osteolysis as the final stage in the absence of neurologic signs. This observation delineates a novel type of recessively inherited peripheral osteolysis and illustrates the long-term skeletal manifestations of acid ceramidase deficiency (Farber's disease) in what appear to be the oldest affected individuals known so far.
© 2016, American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26945816     DOI: 10.1002/art.39659

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN: 2326-5191            Impact factor:   10.995


  4 in total

Review 1.  Acid ceramidase deficiency: Farber disease and SMA-PME.

Authors:  Fabian P S Yu; Samuel Amintas; Thierry Levade; Jeffrey A Medin
Journal:  Orphanet J Rare Dis       Date:  2018-07-20       Impact factor: 4.123

Review 2.  Elusive Roles of the Different Ceramidases in Human Health, Pathophysiology, and Tissue Regeneration.

Authors:  Carolina Duarte; Juliet Akkaoui; Chiaki Yamada; Anny Ho; Cungui Mao; Alexandru Movila
Journal:  Cells       Date:  2020-06-02       Impact factor: 6.600

3.  Parallel Reaction Monitoring reveals structure-specific ceramide alterations in the zebrafish.

Authors:  Tejia Zhang; Sunia A Trauger; Charles Vidoudez; Kim P Doane; Brock R Pluimer; Randall T Peterson
Journal:  Sci Rep       Date:  2019-12-27       Impact factor: 4.379

4.  Estimated prevalence of mucopolysaccharidoses from population-based exomes and genomes.

Authors:  Pâmella Borges; Gabriela Pasqualim; Roberto Giugliani; Filippo Vairo; Ursula Matte
Journal:  Orphanet J Rare Dis       Date:  2020-11-18       Impact factor: 4.123

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.